Skip to main content

Table 1 Patient characteristics

From: Differential roles of the Wip1–p38–p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas

Patient characteristics Number (n=143)
Median age (range) 54 (30–81)
FIGO stage
 I 82 (57%)
 II 20 (14%)
 III 28 (20%)
 IV 13 (9%)
Histology
 Pure type 134 (94%)
 Mixed type 9 (6%)
  Serous 4 (3%)
  Mucinous 2 (1%)
  Endometrioid 2 (1%)
  Cystadenocarcinofibroma 1 (1%)
Positive peritoneal cytology 66 (46%)
Endometriosis
 Present 74 (52%)
 Absent 69 (48%)
Treatment
 Surgery 143 (100%)
  Lymph node adenectomy 112 (78%)
  Lymph node sampling 5 (3%)
 Chemotherapy 136 (95%)
  Platinum 135 (94%)
  Taxane 122 (85%)
  CPT-11 19 (13%)
Residual tumor present 20 (14%)
  1. FIGO International Federation of Gynecology and Obstetrics, CPT-11 camptothecin-11